Physician profile
Gary Stephen Edwards
NPI 1588699904
$1,570.96
in general payments reported to CMS, 2019-2025
15 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $665 · 2021: $267 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $243.28 | 2020 | |
| Janssen Pharmaceuticals, INC | $188.25 | 2019-2020 | |
| Amarin Pharma, INC. | $185.12 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $166.74 | 2019-2021 | |
| Esperion Therapeutics, INC. | $136.22 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $121.97 | 2020 | |
| Lilly USA, LLC | $117.73 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.52 | 2019 | |
| Novo Nordisk INC | $98.29 | 2025 | Wegovy |
| Alkermes, INC. | $87.18 | 2025 | Vivitrol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.00 | 2019 | |
| Pfizer INC. | $24.65 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $18.96 | 2019 | |
| Glaxosmithkline, LLC. | $12.65 | 2019 | |
| Allergan, INC. | $12.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.